Accretion Nutraveda (BOM:544694) Other Financing: ₹-4.5 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544694 Accretion Nutraveda Ltd BOM:544694
21 GF Score
Price ₹283.95
! 3 Warning Signs
View Full Analysis

What is Accretion Nutraveda Other Financing?

Accretion Nutraveda BOM:544694 21 Other Financing is ₹-4.5 Mil as of Mar. 2026. GuruFocus rates BOM:544694 with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Accretion Nutraveda's Other Financing for the six months ended in Mar. 2026 was ₹-1.9 Mil.

Accretion Nutraveda's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-4.5 Mil.

Accretion Nutraveda Other Financing Historical Data

* Premium members only.

The historical data trend for Accretion Nutraveda's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Nutraveda Other Financing Chart

Accretion Nutraveda Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Other Financing
-1.91 -2.39 -2.78 -4.53

Accretion Nutraveda Semi-Annual Data
Mar23 Mar24 Mar25 Sep25 Mar26
Other Financing 0.00 0.00 0.00 -2.62 -1.91
BOM:544694
21GF Score
Accretion Nutraveda Ltd BOM:544694
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Nutraveda Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-4.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₹-4.5 Mil mean?
Accretion Nutraveda (BOM:544694) has a Other Financing of ₹-4.5 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Accretion Nutraveda and its competitors.
Is Accretion Nutraveda's Other Financing too high?
Accretion Nutraveda's current Other Financing is ₹-4.5 Mil. Overall, Accretion Nutraveda has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Nutraveda's Other Financing compare to ZTS?
Accretion Nutraveda's Other Financing of ₹-4.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Accretion Nutraveda and its competitors. Accretion Nutraveda's current Other Financing is ₹-4.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Nutraveda stock overvalued right now?
Accretion Nutraveda (BOM:544694) has a current Other Financing of ₹-4.5 Mil. The current Other Financing is ₹-4.5 Mil. Accretion Nutraveda's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Accretion Nutraveda (BOM:544694), the current Other Financing is ₹-4.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Nutraveda Business Description

Address 27 Xcelon Industrial Park-1, Vasna-Chacharwadi, Taluka Sanand, Ahmedabad, GJ, IND, 382213
Accretion Nutraveda Ltd is engaged in the business of the Manufacturing of Ayurvedic and Nutraceutical products across several dosage forms, including Tablets, Capsules, Oral liquids, Oral Powders, External Preparation and Oils. It is a healthcare focused Company specializing in contract manufacturing, serving domestic as well as export markets in various countries like Sri Lanka, Singapore and the USA. The company offers a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. Its product portfolio includes Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support.
21GF Score

Get the complete analysis for BOM:544694

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹283.95
Price